Melanoma B16-F1 cells coated with fusion protein of mouse calreticulin and virus G-protein coupled receptor induced the antitumor immune response in Balb/C mice

Cancer Biology and Therapy

Volumn 11, Issue 6, 2011, Pages 574-580

  Qin, Ye ^a   Han, Yu ^a   Cao, Chunyu ^a   Ren, Yushan ^a   Li, Chunhong ^a   Wang, Yanlin ^a  

^a CHINA THREE GORGES UNIVERSITY   (China)

Author keywords

Antitumor immune response; Calreticulin; G protein coupled receptor; Melanoma cell

Indexed keywords

CALRETICULIN; CALRETICULIN VIRUS G PROTEIN COUPLED RECEPTOR HYBRID PROTEIN; CELL ANTIGEN; G PROTEIN COUPLED RECEPTOR; HYBRID PROTEIN; MITOXANTRONE; PLASMID DNA; PLASMID VECTOR; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; CELL BASED GENE THERAPY; CELL SURFACE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; EXPRESSION VECTOR; FEMALE; GENE CONSTRUCT; GENE OVEREXPRESSION; GENE SEQUENCE; IMMUNE RESPONSE; MACROPHAGE; MALE; MELANOMA; MELANOMA B16; MOLECULAR CLONING; MOUSE; NONHUMAN; PHAGOCYTOSIS; SEQUENCE ANALYSIS; TUMOR IMMUNITY;

ANIMALS; APOPTOSIS; CALRETICULIN; ENDOPLASMIC RETICULUM; IMMUNITY, ACTIVE; IMMUNOTHERAPY; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED BALB C; RECEPTORS, G-PROTEIN-COUPLED; RECOMBINANT FUSION PROTEINS; SKIN NEOPLASMS; UP-REGULATION;

EID: 79952750136     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.11.6.14414     Document Type: Article

References (26)

1. Rescigno M, Avogadri F, Curigliano G. Challenges and prospects of immunotherapy as cancer treatment. Biochim Biophys Acta 2007; 1776:108-23. (Pubitemid 47332077)
2. Prestwich RJ, Errington F, Hatfield P, Merrick AE, Ilett EJ, Selby PJ, et al. The immune system, is it relevant to cancer development, progression and treatment? Clin Oncol 2008; 20:101-12.
3. Reiman JM, Kmieciak M, Manjili MH, Knutson KL. Tumor immunoediting and immunosculpting pathways to cancer progression. Semin Cancer Biol 2007; 17:275-87. (Pubitemid 47211962)
4. Kepp O, Tesniere A, Schlemmer F, Michaud M, Senovilla L, Kroemer G, et al. Immunogenic cell death modalities and their impact on cancer treatment. Apoptosis 2009; 14:364-75.
5. Ostwald TJ, MacLennan DH. Isolation of a high affinity calcium binding protein from sarcoplasmic reticulum. J Biol Chem 1974; 249:974-9.
6. Fliegel L, Burns K, MacLennan DH, Reithmeier RA, Michalak M. Molecular cloning of the high affinity calcium-binding protein (calreticulin) of skeletal muscle sarcoplasmic reticulum. J Biol Chem 1989; 264:21522-8. (Pubitemid 20028713)
7. Burns K, Duggan B, Atkinson EA, Famulski KS, Nemer M, Michalak M, et al. Modulation of gene expression by calreticulin binding to the glucocorticoid receptor. Nature 1994; 367:476-80. (Pubitemid 24046052)
8. Mery L, Mesaeli N, Michalak M, Opas M, Lew DP, Krause KH. Overexpression of calreticulin increases intracellular Ca2+ storage and decreases store-operated Ca2+ influx. J Biol Chem 1996; 271:9332-9.
9. Lewis JW, Elliott T. Evidence for successive peptide binding and quality control stages during MHC class I assembly. Curr Biol 1998; 8:717-20. (Pubitemid 28286281)
10. Arosa FA, de Jesus O, Porto G, Carmo AM, de Sousa M. Calreticulin is expressed on the cell surface of activated human peripheral blood T lymphocytes in association with major histocompatibility complex I molecules. J Biol Chem 1999; 274:16917-22.
11. Fraser SA, Karimi R, Michalak M, Hudig D. Perforin lytic activity is controlled by calreticulin. J Immunol 2000; 164:4150-5. (Pubitemid 30215072)
12. Henson PM, Bratton DL, Fadok VA. Apoptotic cell removal. Curr Biol 2001; 11:795-805.
13. Hoffmann PR, de Cathelineau AM, Ogden CA, Leverrier Y, Bratton DL, Daleke DL, et al. Phosphatidylserine (PS) induces PS receptor-mediated macropinocytosis and promotes clearance of apoptotic cells. J Cell Biol 2001; 155:649-59. (Pubitemid 34289322)
14. Ogden CA, de Cathelineau A, Hoffmann PR, Bratton D, Ghebrehiwet B, Fadok VA, et al. C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J Exp Med 2001; 194:781-95. (Pubitemid 32983014)
15. Kuraishi T, Manaka J, Kono M, Ishii H, Yamamoto N, Koizumi K, et al. Identification of calreticulin as a marker for phagocytosis of apoptotic cells in Drosophila. Exp Cell Res 2007; 313:500-10. (Pubitemid 46201810)
16. Obeid M, Tesniere A, Ghiringhelli F, Fimia GM, Apetoh L, Kroemer G, et al. Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat Med 2006; 13:54-61.
17. Gardai SJ, McPhillips KA, Frasch SC, Janssen WJ, Starefeldt A, Henson PM, et al. Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte. Cell 2005; 123:321-34. (Pubitemid 41457220)
18. Lauber K, Blumenthal SG, Waibel M, Wesselborg S. Clearance of apoptotic cells: getting rid of the corpses. Mol Cell 2004; 14:277-87. (Pubitemid 38607340)
19. Henson PM, Hume DA. Apoptotic cell removal in development and tissue homeostasis. Trends Immunol 2006; 27:244-50.
20. Apetoh L, Mignot G, Panaretakis T, Kroemer G, Zitvogel L. Immunogenicity of anthracyclines: moving towards more personalized medicine. Trends Mol Med 2008; 14:141-51.
21. Pledgie-Tracy A, Billam M, Hacker A, Michele D, Sobolewski, Casero RA, et al. The role of the polyamine catabolic enzymes SSAT and SMO in the synergistic effects of standard chemotherapeutic agents with a polyamine analogue in human breast cancer cell lines. Cancer Chemocher Pharmacol 2010; 65:1067-81.
22. Cao C, Han Y, Ren Y, Wang Y. Apoptotic B16-F1 cells coated with recombinant calreticulin mediated antitumor immune response in mice. Chin J Cancer Res 2010; 22:253-9.
23. Eggleton P, Llewellyn DH. Pathophysiological roles of calreticulin in autoimmune disease. Scand J Immunol 1999; 49:466-73. (Pubitemid 29243117)
24. Obeid M, Panaretakis T, Joza N, Tufi R, Tesniere A, Kroemer G, et al. Calreticulin exposure is required for the immunogenicity of γ-irradiation and UVC light-induced apoptosis. Cell Death Differ 2007; 14:1848-50. (Pubitemid 47423653)
25. Cao C, Han Y, Ren Y, Wang Y. Mitroxantronemediated apoptotic B16-F1 cells induce specific antitumor immune response. Cell Mol Immunol 2009; 6:469-75.
26. Liu C, Sandford G, Fei G, Nicholas J. G protein selectivity determinant specified by a viral chemokine receptor-conserved region in the C tail of the human herpes virus 8 G protein-coupled receptor. J Virol 2004; 78:2460-71.22.